Pharmaceutical industry innovation and developments /

Bibliographic Details
Corporate Author: ProQuest (Firm)
Other Authors: Mancuso, David A., Grenada, Isobel M.
Format: Electronic eBook
Language:English
Published: Hauppauge, N.Y. : Nova Science, c2011.
Series:Business issues, competition and entrepreneurship series.
Pharmacology-research, safety testing, and regulation series.
Subjects:
Online Access:Click to View
LEADER 02664nam a2200433 a 4500
001 EBC3021409
003 MiAaPQ
005 20200520144314.0
006 m o d |
007 cr cn|||||||||
008 110125s2011 nyua sb 001 0 eng d
010 |z  2011003550 
020 |z 9781612093949 (hardcover) 
020 |a 9781621004394 (electronic bk.) 
035 |a (MiAaPQ)EBC3021409 
035 |a (Au-PeEL)EBL3021409 
035 |a (CaPaEBR)ebr10683067 
035 |a (OCoLC)750642412 
040 |a MiAaPQ  |c MiAaPQ  |d MiAaPQ 
050 4 |a RM301.25  |b .P428 2011 
082 0 4 |a 615/.19  |2 22 
245 0 0 |a Pharmaceutical industry  |h [electronic resource] :  |b innovation and developments /  |c David A. Mancuso and Isobel M. Grenada, editors. 
260 |a Hauppauge, N.Y. :  |b Nova Science,  |c c2011. 
300 |a ix, 182 p. :  |b ill. 
490 1 |a Business issues, competition and entrepreneurship 
490 1 |a Pharmacology-research, safety testing and regulation 
504 |a Includes bibliographical references and index. 
505 0 |a Authorized generic pharmaceuticals : effects on innovation / John R. Thomas -- Authorized generics : an interim report / FTC -- Remarks of J. Thomas Rosch, Commissioner, Federal Trade Commission, before the World Generic Medicine Congress, hearing on "pay-for-delay settlements, authorized generics, and follow-on biologies : thoughts on the how competition law can best protect consumer welfare in the pharmaceutical context" -- Federal R&D, drug discovery, and pricing : insights from the NIH-university-industry relationship / Wendy H. Schacht -- Pharmaceutical R&D and the evolving market for prescription drugs / CBO -- Federal taxation of the drug industry and its effects on new drug development / Gary Guenther -- Pharmaceutical patent litigation settlements : implications for competition and innovation / John R. Thomas -- FDA's authority to regulate drug compounding : a legal analysis / Jennifer Staman -- Promotional spending for prescription drugs / CBO. 
533 |a Electronic reproduction. Ann Arbor, MI : ProQuest, 2015. Available via World Wide Web. Access may be limited to ProQuest affiliated libraries. 
650 0 |a Drug development. 
650 0 |a Pharmaceutical industry. 
650 0 |a Drugs  |x Law and legislation. 
655 4 |a Electronic books. 
700 1 |a Mancuso, David A. 
700 1 |a Grenada, Isobel M. 
710 2 |a ProQuest (Firm) 
830 0 |a Business issues, competition and entrepreneurship series. 
830 0 |a Pharmacology-research, safety testing, and regulation series. 
856 4 0 |u https://ebookcentral.proquest.com/lib/matrademy/detail.action?docID=3021409  |z Click to View